Pfizer’s HYMPAVZI Gains FDA Approval for Expanded Hemophilia Care
NEW YORK, USA – June 8, 2026 Pfizer has secured U.S. Food and Drug Administration (FDA) approval for an...
biotechnology acquisition
Advertisement
GSK to Acquire Nuvalent in $10.6B Lung Cancer Expansion
LONDON, United Kingdom & BOSTON, Massachusetts, USA – June 8, 2026 GSK has announced a definitive agreement to acquire...
Incyte to Acquire Vega Therapeutics for $2 Billion Deal
WILMINGTON, Delaware, USA – June 8, 2026 Incyte Corporation has announced a definitive agreement to acquire Vega Therapeutics, a...
Lilly Acquires Engage Bio for Genetic Medicines
SAN CARLOS, Calif., May 22, 2026 Eli Lilly and Company has acquired Engage Bio, a preclinical biotechnology company focused...
Novartis Acquires Excellergy in $2B Allergy Innovation Deal
Basel, Switzerland | March 27, 2026 Strategic Acquisition Strengthens Allergy Leadership Novartis has announced a major strategic move to...
Advertisement
